News
India's drug regulator is addressing consumer concerns about illegible expiry dates and glossy packaging on medicines by ...
Explore the latest on VYVGART HYTRULO's FDA safety signal and transition challenges. Learn why argenx's balanced risks keep ...
The FDA has eliminated Risk Evaluation and Mitigation Strategies for all currently approved BCMA- and CD19-directed autologous CAR-T cell immunotherapies, determining that the safety program is no ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
DCC agrees with proposal to include Good Distribution Practices as part of Drugs Rules: Gireesh Babu, New Delhi Monday, June 30, 2025, 08:00 Hrs [IST] The Drugs Consultative Commi ...
The administration's cuts to the Department of Health and Human Services are going to do irreparable harm to the nation’s ...
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
Lenacapavir is regarded as a significant step in improving prevention options for people at risk of HIV infection ...
A federal judge in D.C. recently ruled in favor of the U.S. Health Resources and Services Administration by finding that drug manufacturers must obtain pre-approval from HRSA before implementing ...
General Food Labeling Requirements and Labeling-Related Sample Analysis — Domestic and Import” replaces the previous 2010 ...
Bristol Myers Squibb has announced that the FDA has given approval to label updates for Breyanzi and Abecma to treat multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results